Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021007

Expand all

AGENERASE (AMPRENAVIR)
50MG
Marketing Status: Discontinued

Active Ingredient: AMPRENAVIR
Proprietary Name: AGENERASE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021007
Product Number: 001
Approval Date: Apr 15, 1999
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

AGENERASE (AMPRENAVIR)
150MG
Marketing Status: Discontinued

Active Ingredient: AMPRENAVIR
Proprietary Name: AGENERASE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021007
Product Number: 002
Approval Date: Apr 15, 1999
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information